IntrinsicIntrinsic
OverviewFinancialsChartBusiness SummaryFilingsOwnershipValuation

UNITED THERAPEUTICS Corp (UTHR)

Pharmaceutical Preparations

Latest Price
$502.70
TTM P/E
18.01
Normalized P/E
23.67
Div Yield
--
Book Value
148.84
P/B Ratio
3.38

Valuation metrics

adjust assumptions →
EPS: $27.86
Book value / share: $162.60
Formula: √(22.5 × EPS × BVPS)
Graham Number
$319.25
36% downside
Norm. op. income: $980M (median of 7yr)
Tax rate: 22%
Discount rate: 10%
Growth assumption: zero (EPV is a no-growth value)
Earnings Power Value
$241.48
52% downside
Base FCF: $748M (median of recent 5yr)
Growth: 13%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$582.10
+16% upside
EPS: $27.86
Target P/E: 24×
Formula: EPS × P/E
P/E Fair Value
$668.64
+33% upside

Institutional Ownership

98.9% held by institutions
InstitutionSharesValueOwnership %ChangeFiling Date
BlackRock, Inc.5.29M$2.87B12.41%-105.1K2026-06-30
Avoro Capital Advisors LLC2.78M$1.50B6.51%-232.2K2026-06-30
VANGUARD PORTFOLIO MANAGEMENT LLC1.92M$1.04B4.50%-84.3K2026-06-30
VANGUARD CAPITAL MANAGEMENT LLC1.92M$1.04B4.49%-39.3K2026-06-30
STATE STREET CORP1.90M$1.03B4.45%+54.1K2026-06-30
RENAISSANCE TECHNOLOGIES LLC1.71M$925.0M4.00%-78.3K2026-06-30
WELLINGTON MANAGEMENT GROUP LLP1.38M$747.0M3.23%-885.2K2026-06-30
GEODE CAPITAL MANAGEMENT, LLC996.6K$538.0M2.34%-236.4K2026-06-30
Jupiter Topco LLC831.1K$450.0M1.95%--2026-06-30
Caption Management, LLC754.1K$408.0M1.77%-397.5K2026-06-30
View all institutional holders →